CLINICAL_TRIALS
trial_result
· 2026-02-11
Clinical Trial Update: Rivaroxaban in Idiopathic Membranous Nephropathy [Phase 4]
Summary
Ongoing Phase 4 clinical trial evaluating rivaroxaban for idiopathic membranous nephropathy; the study is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Beijing Friendship Hospital | Conditions: Idiopathic Membranous Nephropathy | Phase 4 | Status: RECRUITING